Cargando…

Individualized Vancomycin Dosing with Therapeutic Drug Monitoring and Pharmacokinetic Consultation Service: A Large-Scale Retrospective Observational Study

BACKGROUND: To date, outcome data with a large sample size and data regarding the clinical outcomes of pharmacokinetic-guided (PK) dosing of vancomycin are limited. AIM: We evaluated the pharmacokinetic and clinical outcomes of a PK-guided dosing advisory program, pharmacokinetic consultation servic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sang-Mi, Lee, Hyun-Seung, Hwang, Na-Young, Kim, Kyunga, Park, Hyung-Doo, Lee, Soo-Youn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939511/ https://www.ncbi.nlm.nih.gov/pubmed/33692613 http://dx.doi.org/10.2147/DDDT.S285488

Ejemplares similares

Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury
por: Kim, Sang-Mi, et al.
Publicado: (2021)

Correction: Kim et al. Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury. J. Clin. Med. 2021, 10, 5005
por: Kim, Sang-Mi, et al.
Publicado: (2022)

Serum 5-Hydroxyindoleacetic Acid and Ratio of 5-Hydroxyindoleacetic Acid to Serotonin as Metabolomics Indicators for Acute Oxidative Stress and Inflammation in Vancomycin-Associated Acute Kidney Injury
por: Lee, Hyun-Seung, et al.
Publicado: (2021)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
por: Kim, Dae Il, et al.
Publicado: (2010)

Impact of Vancomycin‐Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin
por: Sunwoo, Jung, et al.
Publicado: (2020)

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals
por: Smit, Cornelis, et al.
Publicado: (2020)

Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia
por: Nham, Eliel, et al.
Publicado: (2022)

Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations
por: Aljutayli, Abdullah, et al.
Publicado: (2022)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
por: Mulubwa, Mwila, et al.
Publicado: (2020)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
por: Zhao, Sixuan, et al.
Publicado: (2021)

Application of Machine Learning Classification to Improve the Performance of Vancomycin Therapeutic Drug Monitoring
por: Lee, Sooyoung, et al.
Publicado: (2022)

Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
por: Ghasemiyeh, Parisa, et al.
Publicado: (2022)

The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
por: Katip, Wasan, et al.
Publicado: (2016)

Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients
por: Shoji, Kensuke, et al.
Publicado: (2021)

Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
por: Wagner, Phillip, et al.
Publicado: (2022)

Intrawound Vancomycin Powder Application for Preventing Surgical Site Infection Following Cranioplasty
por: Youn, Seong Bin, et al.
Publicado: (2023)

Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
por: Monteiro, Joaquim F., et al.
Publicado: (2018)

Model-informed precision dosing in vancomycin treatment
por: Yoon, Sukyong, et al.
Publicado: (2023)

Association between Cardiologist Consultation and Mortality of Stable Patients with Elevated Cardiac Troponin at Admission
por: Oh, Ah Ran, et al.
Publicado: (2021)

1575. Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
por: Wagner, Phillip, et al.
Publicado: (2019)

1540. A Population Pharmacokinetic Model for Vancomycin in Korean Patients Receiving Extracorporeal Membrane Oxygenation Therapy: A Prospective Study
por: Jung, Younghee, et al.
Publicado: (2019)

Population Pharmacokinetics of Vancomycin in Thai Patients
por: Purwonugroho, Tunggul Adi, et al.
Publicado: (2012)

Population Pharmacokinetics of Vancomycin in Pregnant Women
por: Goyal, Rahul K., et al.
Publicado: (2022)

Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results
por: Kim, Byungwook, et al.
Publicado: (2023)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
por: Munir, Muhammad Muaaz, et al.
Publicado: (2021)

Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects
por: Hwang, Inyoung, et al.
Publicado: (2018)

Thyroxine (T4) Autoantibody Interference of Free T4 Concentration Measurement in a Patient With Hashimoto's Thyroiditis
por: Lee, Mi-Na, et al.
Publicado: (2017)

The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study
por: Hwang, Ji-Hee, et al.
Publicado: (2013)

A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea
por: Choi, Rihwa, et al.
Publicado: (2019)

Audit of therapeutic drug monitoring of dosing of vancomycin on an intensive care unit
por: Mason, P, et al.
Publicado: (2002)

117 Evaluating Predicted vs. Actual Vancomycin Pharmacokinetic Target Attainment Using AUC Dosing
por: Boyd, Allison N, et al.
Publicado: (2022)

Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications
por: Hartinger, Jan Miroslav, et al.
Publicado: (2023)

Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects
por: Hwang, Sejung, et al.
Publicado: (2021)

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
por: Mena, Manuel, et al.
Publicado: (2023)

Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients
por: Kim, Yun, et al.
Publicado: (2022)

Clinical pharmacokinetics of vancomycin in the neonate: a review
por: Pacifici, Gian Maria, et al.
Publicado: (2012)

Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Ruczyński, Jarosław, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vje8bckga7s0t5p6gubt8jhqn2